Insight journal - Therapy

Top 15 most partnered therapeutic trends in pharma industry

Posted on 07 August 2014

Tags: , , ,

Current Partnering releases its first update of the article previously published last year on the most partnered therapeutic trends in pharma. The article analyses the most partnered therapeutic targets of 2009-2014 and identifies the areas that have gained in popularity since last year and the new areas that have entered the list.

The study was conducted by analysing the number of partnering deals by therapy area from 2009 – 2014 listed at Current Agreements, a leading deals and alliances database for the life sciences.

The following figure provides a top level overview of partnering activity based on broad therapeutic areas. Our database reveals that the top three most partnered therapeutic areas are oncology, infective diseases and hospital care.

Figure 1: Partnering trends by therapy area 2009-2014

1 trends therapy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source:Current Partnering, 2014

The data in this article is extracted from our recently updated report Trends in Therapeutic Partnering

This article reviews the top 15 specific therapeutic targets based on most partnering deals announced.

Not surprisingly the list is dominated by chronic and life threatening conditions, many of which present in later stages of life. Examples include numerous cancers, infective diseases and other chronic later life conditions.

These therapeutic areas represent an attractive opportunity and unmet need for many big pharma and big biotech companies.

As a result, the deal making in these therapy areas is dominated by top pharma/biotech companies in-licensing from smaller companies in return for upfront, milestone and royalty streams should product candidates make it to market.

In addition, there is increased activity between companies/academia for discovery research in these therapeutic areas.

The following is a countdown of the top 15 therapeutic areas in reverse order since 2009 to mid 2014. The list also compares how each therapy area fared with last year’s statistics.

Top 15 therapeutic areas countdown

#15. Colorectal cancer ↓ from #14 last year

Number of deals announced 2009 to June 2014: 185

Number of deals announced 2007 to June 2013: 206

 

Deal dollars announced 2009 to June 2014: $1.75 billion

Deal dollars announced 2007 to June 2013: $1.99 billion

Colorectal cancer deal frequency

colorectal year

 

 

 

 

 

Source:Current Partnering, 2014

Colorectal cancer partnering by stage of development

colorectal stage

 

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Colorectal Cancer Partnering 2009-2014

#14. Parkinson’s disease ↑ from #17 last year

Number of deals announced 2009 to June 2014: 195

Number of deals announced 2007 to June 2013: 203

 

Deal dollars announced 2009 to June 2014: $7.39 billion

Deal dollars announced 2007 to June 2013: $9.13 billion

Parkinson’s disease deal frequency

 parkinson year

 

 

 

 

 

Source:Current Partnering, 2014

 Parkinson’s disease partnering by stage of development

parkinson stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Parkinson’s Disease Partnering 2009-2014

#13. Solid Tumor ↑ from #15 last year

Number of deals announced 2009 to June 2014: 197

Number of deals announced 2007 to June 2013: 193

 

Deal dollars announced 2009 to June 2014: $10.17 billion

Deal dollars announced 2007 to June 2013: $10.4 billion

Solid Tumor deal frequency

solid tumor year

 

 

 

 

 

 

Source:Current Partnering, 2014

Solid Tumor partnering by stage of development

solid tumor stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Solid Tumor Partnering 2009 -2014

#12. Nutrition & Vitamins ↔ same position as last year

Number of deals announced 2009 to June 2014: 198

Number of deals announced 2007 to June 2013: 234

 

Deal dollars announced 2009 to June 2014: $13.51 billion

Deal dollars announced 2007 to June 2013: $13.94 billion

Nutrition & Vitamins deal frequency

 nutrition year

 

 

 

 

 

 

Source:Current Partnering, 2014

Nutrition & Vitamins partnering by stage of development

nutrition stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

 

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only:Nutrition & Vitamins Partnering 2009 - 2014

#11. Leukemia ↓ from #10 last year

Number of deals announced 2009 to June 2014: 211

Number of deals announced 2007 to June 2013: 254

 

Deal dollars announced 2009 to June 2014: $13.03 billion

Deal dollars announced 2007 to June 2013: $11.75 billion

Leukemia deal frequency

 leukemia year

 

 

 

 

 

Source:Current Partnering, 2014

Leukemia partnering by stage of development

leukemia stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only:Leukemia Partnering 2009-2014

#10. Prostate cancer ↑ from #11 last year

Number of deals announced 2009 to June 2014: 213

Number of deals announced 2007 to June 2013: 238

 

Deal dollars announced 2009 to June 2014: $6.13 billion

Deal dollars announced 2007 to June 2013: $4.83 billion

Prostate cancer deal frequency

 prostate year

 

 

 

 

 

Source:Current Partnering, 2014

Prostate cancer partnering by stage of development

prostate stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Prostate Cancer Partnering 2009-2014

#9. Influenza ↓ from #4 last year

 

Number of deals announced 2009 to June 2014: 226

Number of deals announced 2007 to June 2013: 332

Deal dollars announced 2009 to June 2014: $5.59 billion

Deal dollars announced 2007 to June 2013: $ 7.61billion

Influenza deal frequency

influenza year

 

 

 

 

 

 

 

Source:Current Partnering, 2014

Influenza partnering by stage of development

influenza stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Influenza Partnering 2009-2014

#8. Inflammation ↓ from #7 last year

Number of deals announced 2009 to June 2014: 245

Number of deals announced 2007 to June 2013: 280

Deal dollars announced 2009 to June 2014: $12.56 billion

Deal dollars announced 2007 to June 2013: $6.98 billion

Inflammation deal frequency

 inflammation year

 

 

 

 

 

 

Source:Current Partnering, 2014

Inflammation partnering by stage of development

inflammation stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Inflammatory Partnering 2009-2014

#7. HIV ↓ from #5 last year

Number of deals announced 2009 to June 2014: 256

Number of deals announced 2007 to June 2013: 331

 

Deal dollars announced 2009 to June 2014: $4.24 billion

Deal dollars announced 2007 to June 2013: $5 billion

HIV deal frequency

HIV year

 

 

 

 

 

 

 

Source:Current Partnering, 2014

 HIV partnering by stage of development

HIV stage

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: HIV Partnering 2009-2014

#6. Wound healing ↑ from #9 last year

Number of deals announced 2009 to June 2014: 259

Number of deals announced 2007 to June 2013: 260

Deal dollars announced 2009 to June 2014: $0.95 billion

Deal dollars announced 2007 to June 2013: $1.65 billion

Wound healing deal frequency

 wound healing year

 

 

 

 

 

Source:Current Partnering, 2014

Wound healing partnering by stage of development

wound healing stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only:Wound healing Partnering 2009-2014

#5. Lung cancer ↑ from #8 last year

Number of deals announced 2009 to June 2014: 263

Number of deals announced 2007 to June 2013: 280

 

Deal dollars announced 2009 to June 2014: $5.50 billion

Deal dollars announced 2007 to June 2013: $ 6.54billion

Lung cancer deal frequency

lung cancer year

 

 

 

 

 

 

Source:Current Partnering, 2014

Lung cancer partnering by stage of development

lung cancer stage

 

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Lung Cancer Partnering 2009-2014

#4. Alzheimer’s disease ↑ from #6 last year

Number of deals announced 2009 to June 2014: 282

Number of deals announced 2007 to June 2013: 292

 

Deal dollars announced 2009 to June 2014: $10.86 billion

Deal dollars announced 2007 to June 2013: $ 11.33billion

Alzheimer’s disease deal frequency

 alzheimers year

 

 

 

 

Source:Current Partnering, 2014

 Alzheimer’s disease partnering by stage of development

alzheimers stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only:Alzheimer’s Disease Partnering 2009-2014

#3. Breast cancer ↔ same position as last year

Number of deals announced 2009 to June 2014: 328

Number of deals announced 2007 to June 2013: 332

 

Deal dollars announced 2009 to June 2014: $3.14 billion

Deal dollars announced 2007 to June 2013: $ 7.61billion

Breast cancer deal frequency

 breast cancer year

 

 

 

 

Source:Current Partnering, 2014

Breast cancer partnering by stage of development

breast cancer stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Breast Cancer Partnering 2009-2014

#2. Pain CNS ↔ same position as last year

Number of deals announced 2009 to June 2014: 380

Number of deals announced 2007 to June 2013: 480

 

Deal dollars announced 2009 to June 2014: $10.83 billion

Deal dollars announced 2007 to June 2013: $13.7billion

Pain CNS deal frequency

 pain year

 

 

 

 

Source:Current Partnering, 2014

Pain CNS partnering by stage of development

pain stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Pain Partnering 2009-2014

#1. Diabetes ↔ same position as last year

Number of deals announced 2009 to June 2014: 562

Number of deals announced 2007 to June 2013: 650

 

Deal dollars announced 2009 to June 2014: $26.94 billion

Deal dollars announced 2007 to June 2013: $ 36.72 billion

Diabetes deal frequency

 diabetes year

 

 

 

 

Source:Current Partnering, 2014

Diabetes partnering by stage of development

diabetes stage

 

 

 

 

 

 

 

Source:Current Partnering, 2014

To obtain comprehensive coverage of every deal announced:

  •  All 35 therapeutic areas: Trends in Therapeutic Partnering
  •  This therapeutic area only: Diabetes Partnering 2009-2014

Full list of top 35 therapeutic targets for partnering since 2009 can be found in the table of contents of the report: Trends in Therapeutic Partnering

- By Shamini Thiagarajan, for Current Partnering

Related

2013 Article: Top 15 Most Partnered Therapeutic Targets

Report: Trends in Therapeutic Partnering

View: Full list of therapeutic partnering reports

Report: Partnering Deals and Alliances with Big Pharma                                                  

Report: Partnering Deals and Alliances with Big Biotech

View: Current Partnering Insight Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Insight Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Insight Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Insight Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply